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SPECIFIC AIMS
Thymocyte- and lymphocyte-induced apoptosis during
experimental sepsis is well documented and thought to be
part of the immunosuppressive outcome of sepsis. Since
we recently showed that blockade of C5a in rats with sepsis
(after cecal ligation/puncture) greatly reduces thymocyte
apoptosis but were unable to show direct induction of in
vitro apoptosis in thymocytes by C5a, the aim of the
current study was to investigate the presence and regula-
tion of the C5a receptor (C5aR) on thymocytes during sepsis
and the ability of C5a to directly induce apoptosis under
conditions in which C5aR is up-regulated during sepsis.
PRINCIPAL FINDINGS
1. 125I-labeled recombinant rat C5a (rrC5a) binds
specifically to rat thymocytes
We used binding experiments with 125I-rrC5a to detect
C5aR in rat thymocytes from normal rats. Saturation was
reached at 500 pM C5a. With increasing amounts of
unlabeled rrC5a, binding of 125I-rrC5a to thymocytes could
be competed against. Between 1014 and 1011 M unlabeled
rrC5a, the binding signal achieved with 200 pmol 125I-rrC5a
could be reduced by 50%. Therefore, binding of 125I-
rrC5a appeared to be highly specific and of high affinity.
2. Binding of 125I-rrC5a to rat thymocytes from CLP
rats and from rats treated with lipopolysaccharide
(LPS) or interleukin 6 (IL-6) is increased
To determine whether enhanced binding of C5a occurred
in rat thymocytes during the onset of sepsis, thymocytes
were isolated 3 h after CLP and compared to normal
thymocytes. Significantly increased binding of 125I-rrC5a
to CLP thymocytes was seen. To further investigate medi-
ators possibly responsible for these results, thymocytes from
normal rats were isolated and stimulated in vitro with LPS
and IL-6 at various concentrations for 3 h at 37°C. Each
mediator was capable of significantly increasing 125I-rrC5a
binding to rat thymocytes in a dose-dependent manner.
At concentrations of 100 ng/ml, IL-6 and 500 ng/ml LPS,
binding appeared to be maximally increased.
3. mRNA expression for C5aR is increased in rat
thymocytes during sepsis and after stimulation in
vitro with LPS and IL-6
To further confirm findings of the binding experi-
ments, we conducted RT-PCR experiments to detect
mRNA for C5aR in rat thymocytes. In vitro stimulation
of rat thymocytes with LPS or IL-6 increased mRNA
expression for C5aR in a dose-dependent manner (Fig.
1A). At 3, 6, and 12 h after CLP, mRNA expression was
clearly enhanced compared with that from normal
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Figure 1. Semiquantitative RT-PCR analysis for C5aR mRNA
in rat thymocytes. Thymocytes from normal rats were stimu-
lated with LPS and IL-6 in vitro at different concentrations
(A). Induction of C5aR mRNA in vivo as early as 3 h and as
late as 6 and 12 h after CLP (B). Equal loading conditions
were demonstrated with bands for GAPDH-mRNA produc-
tion (lower panels in both frames). Data are representative of
results from 2 or 3 independent experiments.
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thymocytes (Fig. 1B). Therefore, enhanced binding of
125I-labeled rrC5a during CLP-induced sepsis and after
in vitro stimulation with LPS or IL-6 correlated with an
increased expression of mRNA for C5aR.
4. C5a directly induces apoptosis in thymocytes
from septic rats
In our recent study (mentioned above), we were not
able to demonstrate that C5a directly induces apoptosis
in normal thymocytes in vitro. Therefore, we con-
ducted flow cytometry experiments where we stimu-
lated thymocytes from CLP rats with C5a in vitro under
conditions in which C5aR was up-regulated (as de-
scribed above). Experiments showed the ability of
rrC5a and human C5a to induce thymocyte apoptosis
(as measured by annexin-V binding) in vitro in thymo-
cytes isolated 2 and 3 h after induction of sepsis by CLP
(Fig. 2). Figure 2A summarizes the increase of apopto-
sis achieved by in vitro stimulation with either human
C5a or rrC5a in thymocytes 2 and 3 h after induction of
CLP. Shown is the relative increase of apoptosis com-
pared to the matching control for each experiment (no
C5a addition). Figure 2B shows a typical flow cytometry
experiment demonstrating direct induction of apopto-
sis by either human (100 nM) or rrC5a (30 nM) in
thymocytes from rats 2 h after CLP. Such an effect
could not be detected in thymocytes from normal rats
(data not shown).
5. C5a-induced caspase-3, -6, and -8 activity in
thymocytes from CLP rats
We conducted experiments in thymocytes obtained 3 h
after CLP and measured caspase-3, -6, and -8 activity
enzymatically after in vitro stimulation with human or
rrC5a. Under such conditions, both mediators induced
activities of the three caspases; 30 nM rrC5a appeared
to be more potent than 100 nM human C5a. Under
these conditions, rrC5a increased caspase-3, -6, and -8
activities between 27 and 40%.
CONCLUSIONS
Our findings suggest that C5aR is present in thymocytes
from rats and up-regulated early after the onset of CLP.
We demonstrated that such an increase in C5aR is
accompanied by increased susceptibility of rat thymo-
cytes to C5a-induced in vitro apoptosis. Such direct
evidence for C5a-induced apoptosis in freshly isolated
cells from septic animals has not yet been reported, and
data showing increased C5aR expression in thymocytes
during the onset of sepsis represent a new finding. C5a
has been reported to have harmful effects during the
onset of sepsis, but the role of C5aR expression in sepsis
has not been closely studied. The evidence for a direct
induction of apoptosis in thymocytes by C5a represents
another step in the overall understanding of its poten-
tially harmful effects during the onset of sepsis by
suggesting a mechanism leading to rapid immunosup-
pression. Our findings suggest that suppressing the
harmful effects of C5a during sepsis may be accom-
plished by interception of C5a or blockade of C5aR as
a target for new drugs like antibodies or receptor
antagonists.
Figure 2. Flow cytometry analysis for apoptosis (annexin-V
binding) in rat thymocytes. Rat thymocytes were isolated 2
and 3 h after CLP and not otherwise stimulated or incubated
with huC5a (100 nM) or rrC5a (30 nM) for 30 min at 37°C.
Flow cytometry was performed after staining with annexin-V
for 15 min (A). Data are presented as increases in apoptosis
relative to the corresponding control value in each experi-
ment. Data are from 3–9 independent experiments per bar
graph. Flow cytometric data from thymocytes obtained from
rats 2 h after CLP and not otherwise stimulated or after
exposure to hu C5a or rrC5a (30 min at 37°C) (B).
Figure 3. Schematic diagram showing the increased C5aR
expression during the onset of sepsis and the correlated
susceptibility to C5a-induced apoptosis.
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